Last reviewed · How we verify
NCT03948061
Cardiometabolic Effects of Sweet Cherry Juice
NA trial testing Cherry juice in Obesity in 4 participants. Completed in 25 October 2023.
25 October 2023
Quick facts
| Lead sponsor | USDA, Western Human Nutrition Research Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 4 |
| Start date | 1 October 2019 |
| Primary completion | 25 October 2023 |
| Estimated completion | 25 October 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Cherry juice — full drug profile →
- Placebo beverage — full drug profile →
Conditions studied
- Obesity — all drugs for Obesity →
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
Sponsor
USDA, Western Human Nutrition Research Center — full company profile →
Who can join
Adults 20 to 65, any sex, with Obesity or Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to determine the effects of consuming sweet cherry juice on cardiovascular function, glucose regulation, and lipid status in overweight human subjects. The investigators hypothesize that sweet cherry juice consumption will improve metabolic and physiological status in overweight persons compared to a placebo.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03948061
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cherry juice
Trials testing the same drug.
- NCT03743519 — The Efficacy of a Tart Cherry Drink for the Treatment of Patellofemoral Pain in Recreational Athletes. · NA · completed
- NCT04840160 — Influence of Tart Cherry Juice Intervention on Vascular Function · NA · completed
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other USDA, Western Human Nutrition Research Center trials
Trials by the same sponsor.
- NCT07265648 — Assessing Diet, Stress Scores, and Other Health Metrics in Healthy Northern California Adults · completed
- NCT06883994 — Fermented Vegetables and Gut Microbiome Pilot Study · NA · completed
- NCT06107231 — WHNRC (Western Human Nutrition Research Center) Honey Study · NA · active not recruiting
- NCT05792137 — Postprandial Monocyte Study · NA · completed
- NCT05931471 — Yogurt and GI Health · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03948061 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by USDA, Western Human Nutrition Research Center
- Last refreshed: 27 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03948061.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing